Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP2C9 | P11712 | 1/20 | 1.00 |
| ▸ | ATM | Q13315 | 2/20 | 0.55 |
| ▸ | MAOA | P21397 | 1/20 | 0.48 |
| ▸ | MAOB | P27338 | 1/20 | 0.48 |
| ▸ | HDAC3 | O15379 | 1/20 | 0.47 |
| ▸ | HDAC4 | P56524 | 1/20 | 0.47 |
| ▸ | HDAC1 | Q13547 | 1/20 | 0.47 |
| ▸ | HDAC7 | Q8WUI4 | 1/20 | 0.47 |
| ▸ | HDAC2 | Q92769 | 1/20 | 0.47 |
| ▸ | HDAC10 | Q969S8 | 1/20 | 0.47 |
| ▸ | HDAC11 | Q96DB2 | 1/20 | 0.47 |
| ▸ | HDAC8 | Q9BY41 | 1/20 | 0.47 |
| ▸ | HDAC6 | Q9UBN7 | 1/20 | 0.47 |
| ▸ | HDAC9 | Q9UKV0 | 1/20 | 0.47 |
| ▸ | HDAC5 | Q9UQL6 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.46 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.46 |
| ▸ | ALOX5 | P09917 | 1/20 | 0.46 |
| ▸ | LMNA | P02545 | 2/20 | 0.44 |
| ▸ | TSHR | P16473 | 2/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4292264 | 1.00 | CYP2C9 (1.00) | CYP2C9ATMMAOAMAOBHDAC3 | |
| Fluorescin SCHEMBL31164673 | 0.84 | CYP2C9 (0.71) | CYP2C9ATMALDH1A1ALOX15ALOX5 | |
| Fluorescin SCHEMBL27403 | 0.84 | CYP2C9 (0.71) | CYP2C9ATMALDH1A1ALOX15ALOX5 | |
| Fluorescin SCHEMBL31164674 | 0.84 | CYP2C9 (0.71) | CYP2C9ATMALDH1A1ALOX15ALOX5 | |
| SCHEMBL12037609 | 0.84 | CYP2C9 (0.71) | CYP2C9ATMALDH1A1ALOX15ALOX5 | |
| Fluorescin SCHEMBL31214151 | 0.84 | CYP2C9 (0.71) | CYP2C9ATMALDH1A1ALOX15ALOX5 | |
| Fluorescin SCHEMBL29370997 | 0.84 | CYP2C9 (0.71) | CYP2C9ATMALDH1A1ALOX15ALOX5 | |
| Fluorescin SCHEMBL1507667 | 0.82 | CYP2C9 (0.69) | CYP2C9ATMALDH1A1ALOX15ALOX5 | |
| Fluorescin SCHEMBL1938032 | 0.82 | CYP2C9 (0.69) | CYP2C9ATMALDH1A1ALOX15ALOX5 | |
| SCHEMBL5936698 | 0.82 | CYP2C9 (0.69) | CYP2C9MAOBALDH1A1ALOX5LMNA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20250362303-A1 | CIRCULARLY PERMUTATED HALOALKANE TRANSFERASE FUSION MOLECULES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. (DE) | 2025-11-27 | — | — | US | disclosed |
| US-12371676-B2 | Circularly permutated haloalkane transferase fusion molecules | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2025-07-29 | — | — | US | disclosed |
| US-20250009920-A1 | Monitoring System Based on Etching of Metals | JP LABORATORIES INC. | 2025-01-09 | — | — | US | disclosed |
| US-11655504-B2 | High intensity labeled reactant compositions and methods for sequencing | Quantum-Si Incorporated (US) | 2023-05-23 | — | — | US | disclosed |
| US-20220275350-A1 | CIRCULARLY PERMUTATED HALOALKANE TRANSFERASE FUSION MOLECULES | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e. V. (DE) | 2022-09-01 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-11655504-B2 | High intensity labeled reactant compositions and methods for sequencing | NSUN2, FBL, DNMT3A | CYP2C9 4730/4885ATM 2199/4885MAOA 3088/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.